Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with FHX and IMRT in Advanced Head and Neck Cancer
NCT00462735Phase 2Completed
- Start
- Feb 2007
- Primary completion
- Oct 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in head and neck squamous cell carcinoma (HNSCC). Started Feb 2007; status: completed.
02
Drugs
KL-140
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00462735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462735.